Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (610) 610
Patent (146) 146
Publication (75) 75
Conference Proceeding (18) 18
Book Review (8) 8
Book / eBook (5) 5
Book Chapter (2) 2
Newsletter (2) 2
Data Set (1) 1
Dissertation (1) 1
Reference (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (218) 218
index medicus (137) 137
male (136) 136
chemistry (132) 132
female (132) 132
metallurgy (125) 125
infectious diseases (124) 124
adult (112) 112
hiv infections - drug therapy (105) 105
hiv infections - virology (80) 80
hiv-1 - genetics (79) 79
middle aged (76) 76
general tagging of cross-sectional technologies spanning over several sections of the ipc (75) 75
general tagging of new technological developments (75) 75
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (75) 75
virology (75) 75
electricity (74) 74
basic electric elements (73) 73
inorganic chemistry (72) 72
compounds thereof (71) 71
non-metallic elements (71) 71
processes or means, e.g. batteries, for the direct conversionof chemical into electrical energy (71) 71
immunology (69) 69
hiv (66) 66
hiv-1 - drug effects (66) 66
technical subjects covered by former uspc (64) 64
technical subjects covered by former us classification (63) 63
microbiology (62) 62
pharmacology & pharmacy (61) 61
physics (55) 55
cohort studies (47) 47
anti-hiv agents - therapeutic use (46) 46
genotype (46) 46
mutation (46) 46
viral load (46) 46
cd4 lymphocyte count (44) 44
chemical surface treatment (42) 42
coating by vacuum evaporation, by sputtering, by ion implantationor by chemical vapour deposition, in general (42) 42
coating by vacuum evaporation, by sputtering, by ionimplantation or by chemical vapour deposition, in general (42) 42
coating material with metallic material (42) 42
coating metallic material (42) 42
diffusion treatment of metallic material (42) 42
inhibiting corrosion of metallic material or incrustation ingeneral (42) 42
research (42) 42
surface treatment of metallic material by diffusion into thesurface, by chemical conversion or substitution (42) 42
life sciences (40) 40
antiretroviral therapy (39) 39
hiv-1 (39) 39
hiv-1 - isolation & purification (38) 38
aids (37) 37
chemistry, physical (37) 37
hiv infection (37) 37
human immunodeficiency virus--hiv (37) 37
antiviral agents (36) 36
mortality (36) 36
drug resistance, viral (35) 35
materials science, multidisciplinary (33) 33
therapy (33) 33
optics (32) 32
drug resistance (31) 31
prevalence (31) 31
rna, viral - blood (31) 31
devices or arrangements, the optical operation of which ismodified by changing the optical properties of the medium of thedevices or arrangements for the control of the intensity,colour, phase, polarisation or direction of light, e.g.switching, gating, modulating or demodulating (30) 30
drug therapy (30) 30
france (30) 30
frequency-changing (30) 30
mutations (30) 30
non-linear optics (30) 30
optical analogue/digital converters (30) 30
optical logic elements (30) 30
techniques or procedures for the operation thereof (30) 30
hiv reverse transcriptase - genetics (29) 29
analysis (28) 28
hiv infections - epidemiology (28) 28
antiretroviral therapy, highly active (27) 27
anti-hiv agents - pharmacology (26) 26
health aspects (26) 26
prospective studies (26) 26
young adult (26) 26
drug resistance, viral - genetics (25) 25
hiv infections - immunology (25) 25
treatment failure (25) 25
antiretroviral drugs (24) 24
resistance (24) 24
reverse transcriptase inhibitors - therapeutic use (24) 24
aged (23) 23
electrochemistry (23) 23
immunodeficiency-virus type-1 (23) 23
infection (23) 23
lithium (23) 23
risk factors (23) 23
adolescent (22) 22
microbiology and parasitology (22) 22
performing operations (22) 22
physiological aspects (22) 22
transporting (22) 22
neurosciences (21) 21
research article (21) 21
hiv-1 - classification (20) 20
neurons (20) 20
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (723) 723
French (88) 88
German (33) 33
Portuguese (7) 7
Spanish (6) 6
Chinese (4) 4
Korean (4) 4
Polish (3) 3
Serbian (2) 2
Danish (1) 1
Russian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: Impact on susceptibility to first-line strategies
by Frange, P and Assoumou, L and Descamps, D and Cheret, A and Goujard, C and Tran, L and Gousset, M and Avettand-Fenoel, V and Bocket, L and Fafi-Kremer, S and Guinard, J and Morand-Joubert, L and Nicot, F and Plantier, JC and Rogez, S and Wirden, M and Rouzioux, C and Meyer, L and Chaix, ML and French ANRS CO 6 PRIMO Cohort and ANRS 147 OPTIPRIM Clin Trial and AC11 Resistance Study Grp and French ANRS CO 6 PRIMO Cohort, the ANRS 147 OPTIPRIM Clinical Trial and the AC11 Resistance Study Groups and French ANRS CO 6 PRIMO Cohort the ANRS 147 OPTIPRIM Clinical Trial and the AC11 Resistance Study Groups and on behalf of the French ANRS CO 6 PRIMO Cohort, the ANRS 147 OPTIPRIM Clinical Trial and the AC11 Resistance Study Groups
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 12/2015, Volume 70, Issue 7, pp. 2084 - 2089
Background: Our study describes the prevalence of transmitted drug resistance (TDR) among 1318 French patients diagnosed at the time of primary HIV-1 infection... 
HIV-1 | Resistance-associated mutations | Primary HIV infection | INFECTIOUS DISEASES | primary HIV infection | SURVEILLANCE | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | DRUG-RESISTANCE | MUTATIONS | RILPIVIRINE | PREVALENCE | resistance-associated mutations | SPAIN | Anti-HIV Agents - pharmacology | France - epidemiology | Prevalence | HIV-1 - drug effects | HIV Infections - epidemiology | Humans | Drug Resistance, Viral | Genotype | Male | Mutation, Missense | Genotyping Techniques | HIV-1 - genetics | HIV-1 - classification | Homosexuality, Male | HIV-1 - isolation & purification | Female | HIV Infections - transmission | Disease Transmission, Infectious | Life Sciences | Microbiology and Parasitology | Immunology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with b and non-b subtype hiv-1 viruses
by Lambert-Niclot, S and Charpentier, C and Storto, A and Fofana, D. B and Soulié, C and Fourati, S and Visseaux, B and Wirden, M and Morand-Joubert, L and Masquelier, B and Flandre, P and Calvez, V and Descamps, D and Marcelin, A.-G
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 06/2013, Volume 68, Issue 6, pp. 1237 - 1242
The prevalence of rilpivirine, emtricitabine and tenofovir resistance-associated mutations (RAMs), described in vitro and in vivo, was determined in... 
Primary resistance | Non-nucleoside reverse transcriptase inhibitors | NNRTIs | INFECTIOUS DISEASES | EFFICACY | ECHO | REVERSE-TRANSCRIPTASE | SUSCEPTIBILITY | primary resistance | MICROBIOLOGY | FAILURE | TRIAL | THERAPY | non-nucleoside reverse transcriptase inhibitors | EFAVIRENZ | PHARMACOLOGY & PHARMACY | TMC278 | ETRAVIRINE | Emtricitabine | Adenine - analogs & derivatives | Prevalence | Nitriles - pharmacology | HIV-1 - drug effects | Rilpivirine | HIV Infections - epidemiology | HIV Infections - virology | Humans | Reverse Transcriptase Inhibitors - pharmacology | Deoxycytidine - pharmacology | Genotype | Adenine - pharmacology | Pyrimidines - pharmacology | HIV-1 - genetics | Mutation - genetics | Antiretroviral Therapy, Highly Active | Tenofovir | Mutation - physiology | Drug Resistance, Viral - genetics | Organophosphonates - pharmacology | HIV Infections - drug therapy | Deoxycytidine - analogs & derivatives
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Resistance-associated mutations to etravirine (TMC-125) in antiretroviral-naïve patients infected with non-B HIV-1 subtypes
by Maïga, Almoustapha Issiaka and Descamps, Diane and Morand-Joubert, Laurence and Malet, Isabelle and Derache, Anne and Cisse, Mamadou and Koita, Victoria and Akonde, Alain and Diarra, Bah and Wirden, Marc and Tounkara, Anatole and Verlinden, Yvan and Katlama, Christine and Costagliola, Dominique and Masquelier, Bernard and Calvez, Vincent and Marcelin, Anne-Genevieve
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 02/2010, Volume 54, Issue 2, pp. 728 - 733
Susceptibility to etravirine (ETR), an expanded-spectrum nonnucleoside reverse transcriptase inhibitor (NNRTI), is dependent on the type and number of NNRTI... 
GENETIC DIVERSITY | CLINICAL-SAMPLES | EFFICACY | EXPERIENCED HIV-1-INFECTED PATIENTS | TMC125 ETRAVIRINE | REVERSE-TRANSCRIPTASE | DOUBLE-BLIND | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | PLACEBO-CONTROLLED TRIAL | DRUG-RESISTANCE | UNTREATED PATIENTS | Anti-HIV Agents - pharmacology | HIV-1 - drug effects | HIV Infections - virology | Humans | Genotype | Phylogeny | Pyridazines - pharmacology | HIV-1 - genetics | HIV-1 - classification | Drug Resistance, Viral - genetics | HIV-1 - physiology | Anti-HIV Agents - therapeutic use | HIV Infections - drug therapy | Mutation | Pyridazines - therapeutic use | Antiviral Agents
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Increasing prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-infected patients from 2001 to 2006/2007 in France
by Descamps, Diane and Chaix, Marie-Laure and Montes, Brigitte and Pakianather, Sophie and Charpentier, Charlotte and Storto, Alexandre and Barin, Francis and dos Santos, Georges and Krivine, Anne and Delaugerre, Constance and Izopet, Jacques and Marcelin, Anne-Geneviève and Maillard, Anne and Morand-Joubert, Laurence and Pallier, Coralie and Plantier, Jean-Christophe and Tamalet, Catherine and Cottalorda, Jacqueline and Desbois, Delphine and Calvez, Vincent and Brun-Vezinet, Françoise and Masquelier, Bernard and Costagliola, Dominique and ANRS AC11 Resistance Study Grp and ANRS AC11 Resistance Study Group and on behalf of the ANRS AC11 Resistance Study Group
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 2010, Volume 65, Issue 12, pp. 2620 - 2627
To estimate the prevalence of transmitted drug resistance mutations and non-B subtype circulation in antiretroviral-naive chronically HIV-1-infected patients... 
HIV-1 | France | Resistance surveillance | INFECTIOUS DISEASES | VIRUS | SEROCONVERTERS | VARIANTS | PERFORMANCE | MICROBIOLOGY | TRANSMISSION | THERAPY | FREQUENCY | SURVEILLANCE | PHARMACOLOGY & PHARMACY | IMMUNOASSAY | resistance surveillance | TYPE-1 | Anti-HIV Agents - pharmacology | Prevalence | HIV Infections - epidemiology | Humans | HIV Protease - genetics | Reverse Transcriptase Inhibitors - pharmacology | HIV Reverse Transcriptase - genetics | HIV Seropositivity - drug therapy | Male | HIV Seropositivity - transmission | Anti-HIV Agents - therapeutic use | Female | HIV Infections - transmission | Reverse Transcriptase Inhibitors - therapeutic use | France - epidemiology | HIV-1 - drug effects | HIV Infections - virology | HIV-1 - genetics | HIV-1 - classification | Drug Resistance, Viral - genetics | HIV Seropositivity - epidemiology | HIV Infections - drug therapy | HIV-1 - enzymology | Mutation | Chronic Disease | HIV Seropositivity - virology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses
by S Lambert-Niclot and C Charpentier and A Storto and D B Fofana and C Soulié and S Fourati and B Visseaux and M Wirden and L Morand-Joubert and B Masquelier and P Flandre and V Calvez and D Descamps and A-G Marcelin
The Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 06/2013, Volume 68, Issue 6, p. 1237
  The prevalence of rilpivirine, emtricitabine and tenofovir resistance-associated mutations (RAMs), described in vitro and in vivo, was determined in... 
Antiretroviral drugs | Human immunodeficiency virus--HIV | Mutation | Drug resistance | Polymorphism
Journal Article
Details down arrow
6. Full Text Prevalence of resistance mutations related to integrase inhibitor S/GSK1349572 in HIV-1 subtype B raltegravir-naive and -treated patients
by Malet, Isabelle and Wirden, Marc and Fourati, Slim and Armenia, Daniele and Masquelier, Bernard and Fabeni, Lavinia and Sayon, Sophie and Katlama, Christine and Perno, Carlo Federico and Calvez, Vincent and Marcelin, Anne-Geneviève and Ceccherini-Silberstein, Francesca
Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 7/2011, Volume 66, Issue 7, pp. 1481 - 1483
Objectives To compare the frequency of previously in vitro-selected integrase mutations (T124A, T124A/S153F, S153Y, T124A/S153Y and L101I/T124A/S153Y)... 
Failure | Prevalence | Polymorphism | prevalence | INFECTIOUS DISEASES | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | polymorphism | failure | Anti-HIV Agents - pharmacology | Heterocyclic Compounds, 3-Ring | HIV-1 - drug effects | HIV Infections - virology | Humans | Drug Resistance, Viral | Viral Proteins - genetics | Genotype | Mutation, Missense | HIV-1 - genetics | Sequence Analysis, DNA | Anthracenes - pharmacology | HIV-1 - classification | Anti-HIV Agents - administration & dosage | Pyrrolidinones - administration & dosage | HIV Integrase - genetics | HIV-1 - isolation & purification | Amino Acid Substitution - genetics | HIV Infections - drug therapy | Raltegravir Potassium
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Stable prevalence of genotypic drug resistance mutations but increase in non-B virus among patients with primary HIV-1 infection in France
by Chaix, Marie-Laure and Descamps, Diane and Harzic, Martine and Schneider, Véronique and Deveau, Christiane and Tamalet, Catherine and Pellegrin, Isabelle and Izopet, Jacques and Ruffault, Annick and Masquelier, Bernard and Meyer, Laurence and Rouzioux, Christine and Brun-Vezinet, Françoise and Costagliola, Dominique
AIDS, ISSN 0269-9370, 12/2003, Volume 17, Issue 18, pp. 2635 - 2643
Objective: To evaluate the frequency of drug-resistant HIV-1 viral strains from patients presenting with primary infection in 1999-2000 and to survey the... 
HIV-1 primary infection | Drug resistance | France | Epidemiology | Subtype | INFECTIOUS DISEASES | FITNESS | IMMUNOLOGY | INDIVIDUALS | epidemiology | TRANSMISSION | MUTANTS | IMPACT | POLYMORPHISMS | VIROLOGY | subtype | ACTIVE ANTIRETROVIRAL THERAPY | FREQUENCY | drug resistance | TYPE-1 | PROTEASE | France - epidemiology | Prevalence | HIV Infections - epidemiology | HIV Infections - genetics | Humans | Genotype | Male | RNA, Viral - blood | Phylogeny | HIV-1 - genetics | Mutation - genetics | HIV Protease Inhibitors - therapeutic use | Polymorphism, Genetic | Drug Resistance, Viral - genetics | Female | HIV Infections - drug therapy | Reverse Transcriptase Inhibitors - therapeutic use | Drug Therapy, Combination
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Molecular Characterization of Non-B HIV Type 1 Isolates from Patients of a Department of Infectious Diseases, University Hospital of Bordeaux, France, 1989–2009
by Javaugue, François-Charles and Recordon-Pinson, Patricia and Decoin, Madeleine and Masquelier, Bernard and Cazanave, Charles and Neau, Didier and Dupon, Michel and Ragnaud, Jean-Marie and Fleury, Hervé J
AIDS Research and Human Retroviruses, ISSN 0889-2229, 09/2012, Volume 28, Issue 9, pp. 1124 - 1130
The molecular characterization of non-B HIV type 1 subtypes and the sociodemographic baseline characteristics have been studied for 114 non-B HIV-1-infected... 
Sequence Notes | GENETIC DIVERSITY | INFECTIOUS DISEASES | TRANSMITTED DRUG-RESISTANCE | IMPACT | VIRUS | VIROLOGY | SUBTYPES | SURVEILLANCE | PREVALENCE | MUTATIONS | IMMUNOLOGY | Amino Acid Sequence | France - epidemiology | Pregnancy Complications, Infectious - epidemiology | Humans | Middle Aged | Molecular Sequence Data | Genotype | Male | Phylogeny | HIV-1 - genetics | Sequence Analysis, DNA | Genetic Variation | Pregnancy | Young Adult | env Gene Products, Human Immunodeficiency Virus - genetics | RNA, Viral - genetics | HIV-1 - isolation & purification | Recombination, Genetic | HIV Seropositivity - epidemiology | Adult | Female | pol Gene Products, Human Immunodeficiency Virus - genetics | Life Sciences | Microbiology and Parasitology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Combination Antiretroviral Therapy and the Risk of Myocardial Infarction
by Friis-Moller, N and Sabin, CA and Weber, R and Monforte, AD and El-Sa, WM and Reiss, P and Thiebaut, R and Morfeldt, L and De Wit, S and Pradier, C and Calvo, G and Law, MG and Kirk, O and Phillips, AN and Lundgren, JD and Monteforte, AD and Bartsch, G and Dabis, F and Houyez, F and Loeliger, E and Tressler, R and Weller, I and Sjol, A and Sawitz, A and Rickenbach, M and Pezzotti, P and Krum, E and Meester, R and Lavignolle, V and Mulder, J and van der Meer, J and Sprenger, HG and Koopmans, P and Borleffs, J and Crane, LR and Johnson, MA and Martinelli, C and The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group and DAD Study Grp and Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
The New England Journal of Medicine, ISSN 0028-4793, 11/2003, Volume 349, Issue 21, pp. 1993 - 2003
This prospective, observational study assessed the risk of myocardial infarction among 23,468 HIV-1–infected patients in relation to treatment with combination... 
MONICA PROJECT | HEART-DISEASE | ADULTS | LIPODYSTROPHY | HIV-1-INFECTED PATIENTS | EVENT RATES | ASSOCIATION | UMCG Approved | CORONARY-ARTERY-DISEASE | PROTEASE INHIBITORS | HIV-INFECTED PATIENTS | MEDICINE, GENERAL & INTERNAL | HIV-1 | Myocardial Infarction - chemically induced | Anti-Retroviral Agents - therapeutic use | Myocardial Infarction - epidemiology | Prospective Studies | Follow-Up Studies | Humans | Middle Aged | Risk Factors | Anti-Retroviral Agents - adverse effects | Male | CD4 Lymphocyte Count | Incidence | Regression Analysis | HIV Infections - complications | Adult | Female | HIV Infections - drug therapy | Poisson Distribution | Drug Therapy, Combination | Adverse and side effects | Antiviral agents | Anti-HIV agents | Heart attack | Risk factors | Clinical trials | Therapy | Heart attacks | Metabolism | Human immunodeficiency virus--HIV | Older people
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Combination Antiretroviral Therapy and the Risk of Myocardial Infarction: The Data Collection on Adverse Events of Anti-HIV Drugs (DAD) Study Group
by Friis-Møller, Nina and Sabin, Caroline A and Weber, Rainer and d'Arminio Monforte, Antonella and El-Sadr, Wafaa M and Reiss, Peter and Thiébaut, Rodolphe and Morfeldt, Linda and De Wit, Stephane and Pradier, Christian and Calvo, Gonzalo and Law, Matthew G and Kirk, Ole and Phillips, Andrew N and Lundgren, Jens D and Bartsch, G and Dabis, F and Houyez, F and Loeliger, E and Tressler, R and Weller, I and Sjøl, A and Sawitz, A and Rickenbach, M and Pezzotti, P and Krum, E and Meester, R and Lavignolle, V and Sundström, A and Poll, B and Fontas, E and Torres, F and Petoumenos, K and Kjær, J and Hammer, S and Neaton, J and Sjøl, A and de Wolf, F and van der Ven, E and Zaheri, S and Van Valkengoed, I and Bronsveld, W and Weigel, H and Brinkman, K and Frissen, P and ten Veen, J and Hillebrand, M and van Dam, P and Schieveld, S and Mulder, J and van Gorp, E and Meenhorst, P and van Eeden, A and Danner, S and Claessen, F and Perenboom, R and Eeftinck Schattenkerk, J.K and Godfried, M and Lange, J and Lowe, S and van der Meer, J and Nellen, F and Pogany, K and van der Poll, T and Prins, J and Ruys, T and van der Valk, M and Wit, F and Richter, C and van Leusen, R and Vriesendorp, R and Jeurissen, F and Kauffmann, R and Koger, E and Bravenboer, B and ten Napel, C and Sprenger, H.G and Law, G and ten Kate, R.W and Leemhuis, M and Kroon, F and Schippers, E and Schrey, G and van der Geest, S and Verbon, A and Koopmans, P and Keuter, M and Telgt, D and van der Ven, A and van der Ende, M and Gyssens, I and de Marie, S and Juttmann, J and van der Heul, C and Schneider, M and Borleffs, J and Hoepelman, I and Jaspers, C and Matute, A and Schurink, C and ...
New England Journal of Medicine, ISSN 0028-4793, 11/2003, Volume 349, Issue 21, pp. 1993 - 2003
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Prevalence of resistance mutations related to integrase inhibitor S/GSK1349572 in HIV-1 subtype B raltegravir-naive and -treated patients
by Isabelle Malet and Marc Wirden and Slim Fourati and Daniele Armenia and Bernard Masquelier and Lavinia Fabeni and Sophie Sayon and Christine Katlama and Carlo Federico Perno and Vincent Calvez and Anne-Geneviève Marcelin and Francesca Ceccherini-Silberstein
The Journal of Antimicrobial Chemotherapy, ISSN 0305-7453, 07/2011, Volume 66, Issue 7, p. 1481
To compare the frequency of previously in vitro-selected integrase mutations (T124A, T124A/S153F, S153Y, T124A/S153Y and L101I/T124A/S153Y) conferring... 
Antiretroviral drugs | Human immunodeficiency virus--HIV | Mutation | Drug resistance | Virology
Journal Article
Details down arrow
12. Full Text Variable Impact on Mortality of AIDS-Defining Events Diagnosed during Combination Antiretroviral Therapy: Not All AIDS-Defining Conditions Are Created Equal
by Mocroft, Amanda and Sterne, Jonathan A. C and Egger, Matthias and May, Margaret and Grabar, Sophie and Furrer, Hansjakob and Sabin, Caroline and Fatkenheuer, Gerd and Justice, Amy and Reiss, Peter and D'Arminio Monforte, Antonella and Gill, John and Hogg, Robert and Bonnet, Fabrice and Kitahata, Mari and Staszewski, Schlomo and Casabona, Jordi and Harris, Ross and Saag, Michael and Chêne, Geneviève and Costagliola, Dominique and Dabis, François and de Wolf, Frank and Ledergerber, Bruno and Phillips, Anew and Weller, Ian and Sterne, Jonathan and Abgrall, S and Barin, F and Bentata, M and Billaud, E and Boué, F and Gras, L. A and Prins, J. M and Godfried, M. H and Lange, J. M. A and van der Meer, J. T. M and Nellen, F. J. B and van der Poll, T and Vermeulen, J. N and van Vugt, M and Wit, F. W. M. N and Kuijpers, T. W and Pajkrt, D and Scherpbier, H. J and Back, N. K. T and Berkhout, B and Jurriaans, S and Zaaijer, H. L and van Kan, H. J. M and Antiretroviral Therapy Cohort Collaboration (ART-CC) and Antiretroviral Therapy Cohort Collaboration (ART‐CC)
Clinical Infectious Diseases, ISSN 1058-4838, 4/2009, Volume 48, Issue 8, pp. 1138 - 1151
Background. The extent to which mortality differs following individual acquired immunodeficiency syndrome (AIDS)-defining events (ADEs) has not been assessed... 
HIV/AIDS | Antiretrovirals | HIV | Physicians | Mortality | Pulmonary tuberculosis | AIDS | Death | Epidemiology | Viral load | Carts | Prognosis | Humans | Proportional Hazards Models | AIDS-Related Opportunistic Infections - diagnosis | Male | Acquired Immunodeficiency Syndrome - drug therapy | Lymphoma, AIDS-Related - diagnosis | Lymphoma, AIDS-Related - mortality | AIDS-Related Opportunistic Infections - mortality | Acquired Immunodeficiency Syndrome - mortality | Acquired Immunodeficiency Syndrome - diagnosis | Adult | Anti-HIV Agents - therapeutic use | Female | Acquired Immunodeficiency Syndrome - complications | Drug Therapy, Combination | Cohort Studies | Research | Demographic aspects | United States | Patient outcomes | AIDS (Disease)
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies
by D'Arminio Monforte, Antonella and Abrams, Donald and Pradier, Christian and Weber, Rainer and Reiss, Peter and Bonnet, Fabrice and Kirk, Ole and Law, Matthew and de Wit, Stephane and Friis-Møller, Nina and Phillips, Anew N and Sabin, Caroline A and Lundgren, Jens D and Collins, S and Loeliger, E and Tressler, R and Weller, I and Friis-Møller, N and Worm, S. W and Sabin, C. A and Sjøl, A and Lundgren, J. D and Sawitz, A and Rickenbach, M and Pezzotti, P and Krum, E and Gras, L and Balestre, E and Sundström, A and Poll, B and Fontas, E and Torres, F and Petoumenos, K and Kjaer, J and